Marquette Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
TSC
FFAS
LWA
EFG
GI
WPC
FFA
DLA
VCM
AIM
Marquette Asset Management's ROIV Position: Q3 2026 in Review
Marquette Asset Management held its Roivant Sciences (ROIV) position steady in Q3 2026 at 267 shares worth $9.77K. The position accounts for ﹤0.01% of the portfolio, ranked #270.
Marquette Asset Management first reported a position in ROIV in Q3 2025 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Marquette Asset Management held 267 shares of Roivant Sciences worth $9.77K as of Q3 2026.
- Marquette Asset Management left its Roivant Sciences share count unchanged in Q3 2026.
- Roivant Sciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q3 2026, its #270 holding.
- Marquette Asset Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 5 quarters since.
- 20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.